Berliner N - Search Results

1

Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.

Garber JE, Halabi S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge S, Shapiro CL, Dressler L, Paskett ED, Kimmick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N; Cancer and Leukemia Group B. Garber JE, et al. Among authors: berliner n. J Natl Cancer Inst. 2010 Jul 7;102(13):942-9. doi: 10.1093/jnci/djq211. Epub 2010 Jun 16. J Natl Cancer Inst. 2010. PMID: 20554945 Free PMC article.

2

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N. Abramson N, et al. Among authors: berliner n. J Natl Cancer Inst. 2006 Jul 5;98(13):904-10. doi: 10.1093/jnci/djj262. J Natl Cancer Inst. 2006. PMID: 16818854

3

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.

4

Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.

AlJabban A, Paik H, Aster JC, Berliner N, Brouillard J, Brown JR, Burns KH, Castillo JJ, Card J, Dal Cin P, DeAngelo DJ, Dorfman DM, Ebert BL, Garcia JS, Jacobson CA, Lakhani H, Laubach JP, Ligon AH, Lindeman NI, Lindsley RC, Lovitch SB, Luskin MR, Morgan EA, Nowak A, Petrides A, Pinkus GS, Pozdnyakova O, Steensma DP, Stone RM, Weinberg OK, Winer ES, Kim AS. AlJabban A, et al. Among authors: berliner n. JCO Oncol Pract. 2024 Feb;20(2):220-227. doi: 10.1200/OP.23.00217. Epub 2023 Sep 8. JCO Oncol Pract. 2024. PMID: 37683132

5

Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system.

Parnes A, Leblebjian H, Hamilton J, Smith S, Laubach J, Berliner N. Parnes A, et al. Among authors: berliner n. J Oncol Pharm Pract. 2022 Mar;28(2):421-424. doi: 10.1177/1078155221995885. Epub 2021 Feb 20. J Oncol Pharm Pract. 2022. PMID: 33611974

6

Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation.

Perlstein TS, Pande R, Berliner N, Vanasse GJ. Perlstein TS, et al. Among authors: berliner n. Blood. 2011 Mar 10;117(10):2800-6. doi: 10.1182/blood-2010-09-309708. Epub 2011 Jan 14. Blood. 2011. PMID: 21239700 Free article.

7

Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.

Ritchie BM, Sylvester KW, Reardon DP, Churchill WW, Berliner N, Connors JM. Ritchie BM, et al. Among authors: berliner n. J Thromb Thrombolysis. 2016 Nov;42(4):616-22. doi: 10.1007/s11239-016-1408-6. J Thromb Thrombolysis. 2016. PMID: 27501998 Clinical Trial.

8

A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease.

Vanasse GJ, Jeong JY, Tate J, Bathulapalli H, Anderson D, Steen H, Fleming M, Mattocks K, Telenti A, Fellay J, Justice AC, Berliner N. Vanasse GJ, et al. Among authors: berliner n. Blood. 2011 Nov 17;118(20):5401-8. doi: 10.1182/blood-2011-06-362194. Epub 2011 Sep 16. Blood. 2011. PMID: 21926355 Free PMC article.

9

Congenital and Acquired Disorders of Macrophages and Histiocytes.

Berliner N, Rollins BJ. Berliner N, et al. Hematol Oncol Clin North Am. 2015 Oct;29(5):xiii-xv. doi: 10.1016/j.hoc.2015.07.001. Epub 2015 Aug 14. Hematol Oncol Clin North Am. 2015. PMID: 26461161 No abstract available.

10

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma.

Jeong JY, Levine MS, Abayasekara N, Berliner N, Laubach J, Vanasse GJ. Jeong JY, et al. Among authors: berliner n. J Hematol Oncol. 2015 Apr 16;8:37. doi: 10.1186/s13045-015-0136-2. J Hematol Oncol. 2015. PMID: 25886818 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters